Logo Logo
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2006 | 2003
Anzahl der Publikationen: 14

2022

Rule, Simon; Barreto, Wolney Gois; Briones, Javier; Carella, Angelo M.; Casasnovas, Olivier; Pocock, Chris; Wendtner, Clemens-Martin; Zaja, Francesco; Robson, Susan; MacGregor, Lachlan; Tschopp, Roger R.; Nick, Sonja und Dreyling, Martin (2022): Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase Ill MabCute study. In: Haematologica, Bd. 107, Nr. 2: S. 500-509 [PDF, 811kB]

Noe, Sebastian; Zange, Sabine; Seilmaier, Michael; Antwerpen, Markus H.; Fenzl, Thomas; Schneider, Jochen; Spinner, Christoph D.; Bugert, Joachim J.; Wendtner, Clemens-Martin und Wölfel, Roman (2022): Clinical and virological features of first human monkeypox cases in Germany. In: Infection, Bd. 51, Nr. 1: S. 265-270

2021

Luft, Thomas; Wendtner, Clemens-Martin; Kosely, Florentina; Radujkovic, Aleksandar; Benner, Axel; Korell, Felix; Kihm, Lars; Bauer, Matthias F.; Dreger, Peter und Merle, Uta (23. Juni 2021): EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients. In: Frontiers in Immunology, Bd. 12, 634416 [PDF, 642kB]

Schwarz, Tatjana; Heiss, Kirsten; Mahendran, Yuvaraj; Casilag, Fiordiligie; Kurth, Florian; Sander, Leif E.; Wendtner, Clemens-Martin; Hoechstetter, Manuela A.; Müller, Marcel A.; Sekul, Renate; Drosten, Christian; Stadler, Volker und Corman, Victor M. (23. März 2021): SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. In: Frontiers in Immunology, Bd. 12, 629185 [PDF, 2MB]

Stilgenbauer, Stephan; Morschhauser, Franck; Wendtner, Clemens-Martin; Cartron, Guillaume; Hallek, Michael; Eichhorst, Barbara; Kozloff, Mark F.; Giever, Thomas; Lozanski, Gerard; Jiang, Yanwen; Huang, Huang; Pignataro, Daniela Soriano; Schary, William; Humphrey, Kathryn; Mobasher, Mehrdad und Salles, Gilles (2021): Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440). In: Haematologica, Bd. 106, Nr. 11: S. 2834-2844

2020

Ludolph, Kristina; Hauner, Dagmar; Nüssler, Volkmar; Wendtner, Clemens-Martin und Hauner, Hans (2020): Barrieren für Ernährungstherapie in der stationären Hämatologie/Onkologie. In: Ernahrungs Umschau, Bd. 67, Nr. 9: M536-M544

2019

Wendtner, Clemens-Martin (2019): Ibrutinib: the home run for cure in CLL? In: Blood, Bd. 133, Nr. 19: S. 2003-2004

2018

Cramer, Paula; Tresckow, Julia von; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara und Hallek, Michael (2018): Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial. In: Lancet Oncology, Bd. 19, Nr. 9: S. 1215-1228

2016

Alpermann, Tamara; Schnittger, Susanne; Eder, Christiane; Dicker, Frank; Meggendorfer, Manja; Kern, Wolfgang; Schmid, Christoph; Aul, Carlo; Staib, Peter; Wendtner, Clemens-Martin; Schmitz, Norbert; Haferlach, Claudia und Haferlach, Torsten (2016): Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia. In: Haematologica, Bd. 101, Nr. 2, E55-E58

Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross-Ophoff, Carolin; Langerbeins, Petra; Fink, Anna-Maria; Eichhorst, Barbara; Kreuzer, Karl-Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneba, Michael; Dreyling, Martin; Binder, Mascha; Hallek, Michael; Wendtner, Clemens-Martin; Bergmann, Manuela und Fischer, Kirsten (2016): Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia. In: European Journal of Haematology, Bd. 97, Nr. 3: S. 253-260

Wendtner, Clemens-Martin und Polliack, Aaron (2016): Basophils go wild when mosquitoes bite CLL. In: Leukemia & Lymphoma, Bd. 57, Nr. 10: S. 2243-2244

Cheson, Bruce D.; Brugger, Wolfram; Damaj, Gandhi; Dreyling, Martin; Kahl, Brad; Kimby, Eva; Ogura, Michinori; Weidmann, Eckhart; Wendtner, Clemens-Martin und Zinzani, Pier Luigi (2016): Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update. In: Leukemia & Lymphoma, Bd. 57, Nr. 4: S. 766-782

2006

Schlemmer, Marcus; Wendtner, Clemens-Martin; Falk, Martin; Abdel-Rahman, Sultan; Licht, Thomas; Baumert, Jens; Straka, Christian; Hentrich, Marcus; Salat, Christoph; Hiddemann, Wolfgang und Issels, Rolf-Dieter (2006): Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas. In: Oncology, Nr. 1-2: S. 32-39 [PDF, 150kB]

2003

Schlemmer, M.; Wendtner, Clemens-Martin und Issels, Rolf-Dieter (2003): Ifosfamide with regional hyperthermia in soft-tissue sarcomas. In: Oncology, Nr. 2: S. 76-79 [PDF, 52kB]

Diese Liste wurde am Sat Dec 21 20:43:12 2024 CET erstellt.